Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
AMIA ... Annual Symposium Proceedings. AMIA Symposium
|
January 15, 2024
Extracting Thyroid Nodules Characteristics from Ultrasound Reports Using Transformer-based Natural Language Processing Methods
Aman Pathak, Zehao Yu, Daniel Paredes, et al.
Journal of the Endocrine Society
|
January 1, 2026
Improving MASLD Risk Stratification in Young Adults with Cardiometabolic Risk Factors and Insulin Resistance Assessment
Anu Sharma, Eddison Godinez Leiva, Srilaxmi Kalavalapalli, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 11, 2026
Severity of MASH Activity by Iron-Corrected MRI Predicts Insulin Resistance and Cardiometabolic Risk in Type 2 Diabetes
Andrea Ortiz Rocha, Srilaxmi Kalavalapalli, Eddison Godinez Leiva, et al.
Diabetes, Obesity & Metabolism
|
April 29, 2026
High Prevalence of Metabolic Dysfunction-Associated Steatohepatitis With Significant Fibrosis in Primary Care and Endocrinology Clinics
Srilaxmi Kalavalapalli, Eddison Godinez Leiva, Andrea Ortiz Rocha, et al.
Obesity (Silver Spring, Md.)
|
September 24, 2024
Obesity increases the risk of hepatic fibrosis in young adults with type 2 diabetes mellitus: the need to screen
Anu Sharma, Eddison Godina Leiva, Srilaxmi Kalavalapalli, et al.
Journal of Hepatology
|
January 17, 2025
Pan-PPAR agonist lanifibranor improves insulin resistance and hepatic steatosis in patients with T2D and MASLD
Diana Barb, Srilaxmi Kalavalapalli, Eddison Godinez Leiva, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
AMIA ... Annual Symposium Proceedings. AMIA Symposium
|
January 15, 2024
Extracting Thyroid Nodules Characteristics from Ultrasound Reports Using Transformer-based Natural Language Processing Methods
Aman Pathak, Zehao Yu, Daniel Paredes, et al.
Journal of the Endocrine Society
|
January 1, 2026
Improving MASLD Risk Stratification in Young Adults with Cardiometabolic Risk Factors and Insulin Resistance Assessment
Anu Sharma, Eddison Godinez Leiva, Srilaxmi Kalavalapalli, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 11, 2026
Severity of MASH Activity by Iron-Corrected MRI Predicts Insulin Resistance and Cardiometabolic Risk in Type 2 Diabetes
Andrea Ortiz Rocha, Srilaxmi Kalavalapalli, Eddison Godinez Leiva, et al.
Diabetes, Obesity & Metabolism
|
April 29, 2026
High Prevalence of Metabolic Dysfunction-Associated Steatohepatitis With Significant Fibrosis in Primary Care and Endocrinology Clinics
Srilaxmi Kalavalapalli, Eddison Godinez Leiva, Andrea Ortiz Rocha, et al.
Obesity (Silver Spring, Md.)
|
September 24, 2024
Obesity increases the risk of hepatic fibrosis in young adults with type 2 diabetes mellitus: the need to screen
Anu Sharma, Eddison Godina Leiva, Srilaxmi Kalavalapalli, et al.
Journal of Hepatology
|
January 17, 2025
Pan-PPAR agonist lanifibranor improves insulin resistance and hepatic steatosis in patients with T2D and MASLD
Diana Barb, Srilaxmi Kalavalapalli, Eddison Godinez Leiva, et al.
Page
of 1